101 related articles for article (PubMed ID: 8476205)
1. Butyramide and monobutyrin: growth inhibitory and differentiating agents.
Lea MA; Xiao Q; Sadhukhan A; Sharma S; Newmark HL
Anticancer Res; 1993; 13(1):145-9. PubMed ID: 8476205
[TBL] [Abstract][Full Text] [Related]
2. Discordant effects of butyrate analogues on erythroleukemia cell proliferation, differentiation and histone deacetylase.
Lea MA; Tulsyan N
Anticancer Res; 1995; 15(3):879-83. PubMed ID: 7645975
[TBL] [Abstract][Full Text] [Related]
3. Depletion of sodium butyrate from the culture medium of Friend erythroleukemia cells undergoing differentiation.
Friend C; Zajac-Kaye M; Holland JG; Pogo BG
Cancer Res; 1987 Jan; 47(2):378-82. PubMed ID: 3466690
[TBL] [Abstract][Full Text] [Related]
4. Tributyrin: a prodrug of butyric acid for potential clinical application in differentiation therapy.
Chen ZX; Breitman TR
Cancer Res; 1994 Jul; 54(13):3494-9. PubMed ID: 8012972
[TBL] [Abstract][Full Text] [Related]
5. Differential hemoglobin synthesis in murine erythroleukemic cells: hemin effects.
Zucker RM; Umlas ME; Decal DL; Whittington KB
Cell Biochem Funct; 1987 Jan; 5(1):27-35. PubMed ID: 3469035
[TBL] [Abstract][Full Text] [Related]
6. Releasing effect of thymidine on G1 phase arrest of erythroleukemia cells caused by FUDR and HMBA.
Bin X; DiLiberto M; Rifkind RA; Marks PA
Zhongguo Yao Li Xue Bao; 1984 Jun; 5(2):133-7. PubMed ID: 6235712
[No Abstract] [Full Text] [Related]
7. [Effect of sodium butyrate on cell proliferation and alphafetoprotein synthesis of rat hepatoma cells (CBRH-7919) in vitro].
Yeh HJ; Chu TH; Chen RM
Shi Yan Sheng Wu Xue Bao; 1985 Mar; 18(1):105-17. PubMed ID: 2422858
[No Abstract] [Full Text] [Related]
8. Inhibitory effects of tea extracts and (-)-epigallocatechin gallate on DNA synthesis and proliferation of hepatoma and erythroleukemia cells.
Lea MA; Xiao Q; Sadhukhan AK; Cottle S; Wang ZY; Yang CS
Cancer Lett; 1993 Feb; 68(2-3):231-6. PubMed ID: 8443796
[TBL] [Abstract][Full Text] [Related]
9. Alteration in proportions of histone H1 variants during the differentiation of murine erythroleukaemic cells.
Helliger W; Lindner H; Grübl-Knosp O; Puschendorf B
Biochem J; 1992 Dec; 288 ( Pt 3)(Pt 3):747-51. PubMed ID: 1471988
[TBL] [Abstract][Full Text] [Related]
10. Induction of histone acetylation and growth regulation in eryrthroleukemia cells by 4-phenylbutyrate and structural analogs.
Lea MA; Randolph VM; Hodge SK
Anticancer Res; 1999; 19(3A):1971-6. PubMed ID: 10470142
[TBL] [Abstract][Full Text] [Related]
11. [Ascites supernatant from Ehrlich carcinoma enhances the effect of differentiation inducers on mouse erythroleukemia cells].
Hu JS; Huang J; Zhen YS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1986 Aug; 8(4):286-90. PubMed ID: 2953477
[No Abstract] [Full Text] [Related]
12. Growth and differentiation of human and murine erythroleukemia cell lines in serum-free synthetic medium.
Pessano S; McNab A; Rovera G
Cancer Res; 1981 Sep; 41(9 Pt 1):3592-6. PubMed ID: 7020933
[TBL] [Abstract][Full Text] [Related]
13. [Comparative analysis of differentiating and apoptogenic effects of cytidine, thymidine, and guanosine on cells of human erythromyeloleukemic cell line K562].
Volkova TO; Malysheva IE; Nemova NN
Vopr Med Khim; 2002; 48(6):586-93. PubMed ID: 12698558
[TBL] [Abstract][Full Text] [Related]
14. Induction of cell differentiation potentiates apoptosis triggered by prior exposure to DNA-damaging drugs.
Bhatia U; Traganos F; Darzynkiewicz Z
Cell Growth Differ; 1995 Aug; 6(8):937-44. PubMed ID: 8547222
[TBL] [Abstract][Full Text] [Related]
15. Control of hemoglobin synthesis in erythroid differentiating K562 cells. I. Role of iron in erythroid cell heme synthesis.
Kawasaki N; Morimoto K; Tanimoto T; Hayakawa T
Arch Biochem Biophys; 1996 Apr; 328(2):289-94. PubMed ID: 8645006
[TBL] [Abstract][Full Text] [Related]
16. Demonstration of commitment by K562 human erythroleukemia cells.
Rowley PT; Ohlsson-Wilhelm BM
Prog Clin Biol Res; 1985; 191():217-31. PubMed ID: 3863148
[TBL] [Abstract][Full Text] [Related]
17. Butyrate analogue, isobutyramide, inhibits tumor growth and time to androgen-independent progression in the human prostate LNCaP tumor model.
Gleave ME; Sato N; Sadar M; Yago V; Bruchovsky N; Sullivan L
J Cell Biochem; 1998 Jun; 69(3):271-81. PubMed ID: 9581866
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative effects of N1,N4-dibenzylputrescine in human and rodent tumor cells.
Aizencang G; Harari P; Buldain G; Guerra L; Pickart M; Hernandez P; Frydman B
Cell Mol Biol (Noisy-le-grand); 1998 Jun; 44(4):615-25. PubMed ID: 9678897
[TBL] [Abstract][Full Text] [Related]
19. Alterations in membrane lipid dynamics of leukemic cells undergoing growth arrest and differentiation: dependency on the inducing agent.
Nathan I; Ben-Valid I; Henzel R; Masalha H; Baram SN; Dvilansky A; Parola AH
Exp Cell Res; 1998 Mar; 239(2):442-6. PubMed ID: 9521862
[TBL] [Abstract][Full Text] [Related]
20. The effect of added H1 histone and polylysine on DNA synthesis and cell division of cultured mammalian cells.
Kundahl E; Richman R; Flickinger RA
J Cell Physiol; 1981 Sep; 108(3):291-8. PubMed ID: 6945308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
